Journal of International Oral Health

ORIGINAL RESEARCH
Year
: 2021  |  Volume : 13  |  Issue : 1  |  Page : 17--23

Efficacy of 3% Psidium guajava local drug delivery in the treatment of chronic periodontitis: A randomized controlled trial


H Manohar Sharma1, PC Deepika1, MP Venkatesh2, S Chandan3, Pratibha Shashikumar1 
1 Department of Periodontology, JSS Dental College & Hospital, JSS Academy of Higher Education & Research, Mysuru, India
2 Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru, India
3 Department of Biotechnology and Bioinformatics, Department of Water and Health, JSS Academy of Higher Education & Research, Mysuru, India

Correspondence Address:
Dr. H Manohar Sharma
Department of Periodontology, JSS Dental College & Hospital, JSS Academy of Higher Education & Research, Mysuru.
India

Aim: Herbal products are increasingly used as therapeutic agents in the prevention and management of periodontal diseases to preclude the side effects of antibiotics. A recent addition to the list is the leaves of P guajava, as they possess antimicrobial, anti-inflammatory, and antioxidant properties. This study evaluates the effects of the adjunctive use of 3% P. guajava local drug delivery in the management of chronic periodontitis. Materials and Methods: This was a split-mouth study involving contralateral sites in 15 patients (30 sites), who were randomly treated with either 3% P. guajava gel local drug delivery along with scaling and root planing (SRP) or SRP alone. The primary objective was to evaluate pocket probing depth (PPD), clinical attachment level (CAL), and colony counts of A.actenomycetemcomitans (Aa) and P.gingivalis (Pg); the secondary objective was to evaluate plaque, gingival, and bleeding scores. All parameters were assessed at baseline, one month and three months. The data were analyzed by using SPSS 18.5. Results: There was a significant overall improvement in clinical parameters over the study period. There was a statistically significant reduction in site-specific indices, PPD (2.74 ± 0.283), and gain in CAL (2.8 ± 0.152) in the test sites at three months. Microbiological analysis showed a significant reduction in the colony counts of Aa (17.4 ± 0.026) and Pg (22.7 ± 1.225) in the test sites at one and three months. (P < 0.001). Conclusion: Improvements in clinical and microbiological parameters showed that adjunctive use of locally delivered 3% P. guajava gel is effective in the management of chronic periodontitis.


How to cite this article:
Manohar Sharma H, Deepika P C, Venkatesh M P, Chandan S, Shashikumar P. Efficacy of 3% Psidium guajava local drug delivery in the treatment of chronic periodontitis: A randomized controlled trial.J Int Oral Health 2021;13:17-23


How to cite this URL:
Manohar Sharma H, Deepika P C, Venkatesh M P, Chandan S, Shashikumar P. Efficacy of 3% Psidium guajava local drug delivery in the treatment of chronic periodontitis: A randomized controlled trial. J Int Oral Health [serial online] 2021 [cited 2021 Feb 26 ];13:17-23
Available from: https://www.jioh.org/article.asp?issn=0976-7428;year=2021;volume=13;issue=1;spage=17;epage=23;aulast=Manohar;type=0